X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/02/22/2833676/0/en/Ashvattha-Therapeutics-Announces-First-Patient-Enrolled-in-Expanded-Phase-1-2-Study-of-Imaging-Agent-18F-OP-801-in-Additional-Neurological-Indications.html
https://www.globenewswire.com//news-release/2024/02/14/2829078/0/en/Ashvattha-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/01/04/2803993/0/en/Ashvattha-Therapeutics-Announces-the-Appointment-of-Mehdi-Paborji-as-Senior-Vice-President-of-Technical-Operations.html
https://www.globenewswire.com/news-release/2023/11/20/2783236/0/en/Ashvattha-Therapeutics-to-Participate-in-Upcoming-Ophthalmology-Conferences.html
https://www.globenewswire.com//news-release/2023/11/01/2771178/0/en/Ashvattha-Therapeutics-Announces-First-Patient-Dosed-via-Subcutaneous-Administration-of-Anti-Angiogenic-Therapeutic-D-4517-2-for-Wet-AMD-and-DME-in-Phase-2-Chronic-Dosing-Study.html
https://www.globenewswire.com//news-release/2023/10/09/2756666/0/en/Ashvattha-Therapeutics-Announces-Appointment-of-Dr-Sakura-Minami-as-Vice-President-of-Translational-Medicine-and-Nonclinical-Development-and-Sarah-Thayer-as-Head-of-Clinical-Operat.html
https://www.globenewswire.com//news-release/2023/08/22/2729494/0/en/Ashvattha-Therapeutics-Presents-Promising-Preclinical-Data-on-New-Dendranib-Nanomedicine-Candidate-ASH41020-at-the-16th-International-Society-of-Neuroimmunology-Congress-ISNI.html
https://www.globenewswire.com/news-release/2023/08/15/2725465/0/en/Ashvattha-Therapeutics-Announces-Poster-Presentation-of-Preclinical-Data-on-New-Dendranib-Nanomedicine-Candidate-at-the-16th-International-Society-of-Neuroimmunology-Congress-ISNI.html
https://www.globenewswire.com/news-release/2023/05/31/2679395/0/en/Ashvattha-Therapeutics-Expands-Leadership-Team-with-Appointment-of-Paul-E-Cayer-as-Chief-Financial-Officer-and-Mahesh-Karande-to-the-Board-of-Directors.html
https://www.globenewswire.com/news-release/2023/04/26/2655535/0/en/Ashvattha-Therapeutics-Presents-Preclinical-Data-on-anti-VEGF-Nanomedicine-D-4517-2-at-the-2023-ARVO-Annual-Meeting.html
Market Place
Share 
